First-line treatment typically involves: Methotrexate the most commonly prescribed conventional synthetic DMARD Sulfasalazine or hydroxychloroquine alternative or combination options Leflunomide for patients who cannot tolerate methotrexate These medications are usually combined with short-term corticosteroids (such as prednisolone) to provide rapid symptom relief whilst DMARDs take effect, which can take several weeks to months
Additionally, their under-development triple agonist, Retatrutide, has shown unprecedented weight loss effects in phase 2 clinical trials
This personalized assessment helps us weigh the potential benefits against any risks, ensuring that Tirzepatide is a safe option for you
Prescription medications produce dramatic, clinically significant weight loss in controlled trials
Understanding Retatrutide Units and Dosage Measurements Retatrutide is dosed in milligrams (mg), not 'units'
Tesamorelin GH-axis analog studied in visceral adiposity and lipid metabolism research